nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP2D6—breast cancer	0.196	0.538	CbGaD
Oxymorphone—CYP3A4—breast cancer	0.168	0.462	CbGaD
Oxymorphone—CYP3A4—Exemestane—breast cancer	0.0384	0.103	CbGbCtD
Oxymorphone—CYP2D6—Idarubicin—breast cancer	0.0347	0.093	CbGbCtD
Oxymorphone—CYP3A4—Letrozole—breast cancer	0.0327	0.0876	CbGbCtD
Oxymorphone—CYP3A4—Anastrozole—breast cancer	0.0291	0.0781	CbGbCtD
Oxymorphone—CYP3A4—Toremifene—breast cancer	0.0266	0.0714	CbGbCtD
Oxymorphone—CYP3A4—Fulvestrant—breast cancer	0.0248	0.0664	CbGbCtD
Oxymorphone—CYP3A4—Thiotepa—breast cancer	0.0221	0.0592	CbGbCtD
Oxymorphone—CYP3A4—Ixabepilone—breast cancer	0.0202	0.0541	CbGbCtD
Oxymorphone—CYP3A4—Lapatinib—breast cancer	0.0194	0.0521	CbGbCtD
Oxymorphone—CYP2D6—Vinorelbine—breast cancer	0.017	0.0454	CbGbCtD
Oxymorphone—CYP2D6—Tamoxifen—breast cancer	0.0153	0.041	CbGbCtD
Oxymorphone—CYP3A4—Raloxifene—breast cancer	0.0147	0.0395	CbGbCtD
Oxymorphone—CYP3A4—Vinorelbine—breast cancer	0.0108	0.0289	CbGbCtD
Oxymorphone—CYP2D6—Vinblastine—breast cancer	0.0104	0.028	CbGbCtD
Oxymorphone—CYP3A4—Tamoxifen—breast cancer	0.00973	0.0261	CbGbCtD
Oxymorphone—CYP3A4—Mitoxantrone—breast cancer	0.00949	0.0254	CbGbCtD
Oxymorphone—CYP3A4—Paclitaxel—breast cancer	0.00757	0.0203	CbGbCtD
Oxymorphone—CYP3A4—Irinotecan—breast cancer	0.00747	0.02	CbGbCtD
Oxymorphone—CYP3A4—Vinblastine—breast cancer	0.00664	0.0178	CbGbCtD
Oxymorphone—CYP2D6—Doxorubicin—breast cancer	0.00642	0.0172	CbGbCtD
Oxymorphone—CYP3A4—Docetaxel—breast cancer	0.00548	0.0147	CbGbCtD
Oxymorphone—CYP3A4—Doxorubicin—breast cancer	0.00408	0.0109	CbGbCtD
Oxymorphone—Methylnaltrexone—CYP2D6—breast cancer	0.000306	0.0773	CrCbGaD
Oxymorphone—Buprenorphine—ABCG2—breast cancer	0.000288	0.0727	CrCbGaD
Oxymorphone—Naloxone—ESR1—breast cancer	0.00028	0.0707	CrCbGaD
Oxymorphone—Dihydrocodeine—CYP2D6—breast cancer	0.00026	0.0658	CrCbGaD
Oxymorphone—Hydromorphone—PTGS1—breast cancer	0.000243	0.0614	CrCbGaD
Oxymorphone—Dihydrocodeine—CYP3A4—breast cancer	0.000223	0.0564	CrCbGaD
Oxymorphone—Hydrocodone—CYP2D6—breast cancer	0.0002	0.0504	CrCbGaD
Oxymorphone—Oxycodone—CYP2D6—breast cancer	0.000182	0.046	CrCbGaD
Oxymorphone—Hydrocodone—CYP3A4—breast cancer	0.000171	0.0432	CrCbGaD
Oxymorphone—Buprenorphine—CYP2D6—breast cancer	0.000168	0.0424	CrCbGaD
Oxymorphone—Hydromorphone—CYP2D6—breast cancer	0.000165	0.0418	CrCbGaD
Oxymorphone—Naltrexone—ABCB1—breast cancer	0.000163	0.0412	CrCbGaD
Oxymorphone—Oxycodone—CYP3A4—breast cancer	0.000156	0.0394	CrCbGaD
Oxymorphone—Buprenorphine—CYP3A4—breast cancer	0.000144	0.0363	CrCbGaD
Oxymorphone—Naloxone—CYP3A4—breast cancer	0.000143	0.0361	CrCbGaD
Oxymorphone—Hydromorphone—CYP3A4—breast cancer	0.000142	0.0358	CrCbGaD
Oxymorphone—Morphine—CYP2D6—breast cancer	0.000141	0.0355	CrCbGaD
Oxymorphone—Naloxone—ALB—breast cancer	0.000125	0.0315	CrCbGaD
Oxymorphone—Morphine—CYP3A4—breast cancer	0.000121	0.0305	CrCbGaD
Oxymorphone—Buprenorphine—ABCB1—breast cancer	0.00012	0.0303	CrCbGaD
Oxymorphone—Naloxone—ABCB1—breast cancer	0.000119	0.03	CrCbGaD
Oxymorphone—Morphine—ABCB1—breast cancer	0.0001	0.0254	CrCbGaD
Oxymorphone—Visual impairment—Methotrexate—breast cancer	7.04e-05	0.000355	CcSEcCtD
Oxymorphone—Confusional state—Capecitabine—breast cancer	7.03e-05	0.000355	CcSEcCtD
Oxymorphone—Tachycardia—Docetaxel—breast cancer	7.03e-05	0.000354	CcSEcCtD
Oxymorphone—Feeling abnormal—Paclitaxel—breast cancer	7e-05	0.000353	CcSEcCtD
Oxymorphone—Skin disorder—Docetaxel—breast cancer	7e-05	0.000353	CcSEcCtD
Oxymorphone—Oedema—Capecitabine—breast cancer	6.97e-05	0.000352	CcSEcCtD
Oxymorphone—Bradycardia—Epirubicin—breast cancer	6.96e-05	0.000351	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Paclitaxel—breast cancer	6.95e-05	0.00035	CcSEcCtD
Oxymorphone—Diarrhoea—Gemcitabine—breast cancer	6.94e-05	0.00035	CcSEcCtD
Oxymorphone—Dizziness—Irinotecan—breast cancer	6.89e-05	0.000347	CcSEcCtD
Oxymorphone—Anorexia—Docetaxel—breast cancer	6.87e-05	0.000346	CcSEcCtD
Oxymorphone—Shock—Capecitabine—breast cancer	6.86e-05	0.000346	CcSEcCtD
Oxymorphone—Nervous system disorder—Capecitabine—breast cancer	6.84e-05	0.000345	CcSEcCtD
Oxymorphone—Eye disorder—Methotrexate—breast cancer	6.83e-05	0.000344	CcSEcCtD
Oxymorphone—Diarrhoea—Fluorouracil—breast cancer	6.83e-05	0.000344	CcSEcCtD
Oxymorphone—Tachycardia—Capecitabine—breast cancer	6.81e-05	0.000343	CcSEcCtD
Oxymorphone—Cardiac disorder—Methotrexate—breast cancer	6.78e-05	0.000342	CcSEcCtD
Oxymorphone—Skin disorder—Capecitabine—breast cancer	6.77e-05	0.000342	CcSEcCtD
Oxymorphone—Urinary tract disorder—Epirubicin—breast cancer	6.75e-05	0.00034	CcSEcCtD
Oxymorphone—Urticaria—Paclitaxel—breast cancer	6.75e-05	0.00034	CcSEcCtD
Oxymorphone—Hyperhidrosis—Capecitabine—breast cancer	6.74e-05	0.00034	CcSEcCtD
Oxymorphone—Hypotension—Docetaxel—breast cancer	6.73e-05	0.000339	CcSEcCtD
Oxymorphone—Abdominal pain—Paclitaxel—breast cancer	6.72e-05	0.000339	CcSEcCtD
Oxymorphone—Body temperature increased—Paclitaxel—breast cancer	6.72e-05	0.000339	CcSEcCtD
Oxymorphone—Urethral disorder—Epirubicin—breast cancer	6.7e-05	0.000338	CcSEcCtD
Oxymorphone—Anorexia—Capecitabine—breast cancer	6.65e-05	0.000335	CcSEcCtD
Oxymorphone—Angiopathy—Methotrexate—breast cancer	6.63e-05	0.000334	CcSEcCtD
Oxymorphone—Vomiting—Irinotecan—breast cancer	6.63e-05	0.000334	CcSEcCtD
Oxymorphone—Vomiting—Mitoxantrone—breast cancer	6.63e-05	0.000334	CcSEcCtD
Oxymorphone—Immune system disorder—Methotrexate—breast cancer	6.6e-05	0.000333	CcSEcCtD
Oxymorphone—Dizziness—Fluorouracil—breast cancer	6.6e-05	0.000333	CcSEcCtD
Oxymorphone—Visual impairment—Epirubicin—breast cancer	6.59e-05	0.000332	CcSEcCtD
Oxymorphone—Mediastinal disorder—Methotrexate—breast cancer	6.59e-05	0.000332	CcSEcCtD
Oxymorphone—Dermatitis—Mitoxantrone—breast cancer	6.56e-05	0.000331	CcSEcCtD
Oxymorphone—Dermatitis—Irinotecan—breast cancer	6.56e-05	0.000331	CcSEcCtD
Oxymorphone—Headache—Irinotecan—breast cancer	6.53e-05	0.000329	CcSEcCtD
Oxymorphone—Headache—Mitoxantrone—breast cancer	6.53e-05	0.000329	CcSEcCtD
Oxymorphone—Hypotension—Capecitabine—breast cancer	6.52e-05	0.000329	CcSEcCtD
Oxymorphone—Insomnia—Docetaxel—breast cancer	6.52e-05	0.000328	CcSEcCtD
Oxymorphone—Vomiting—Gemcitabine—breast cancer	6.45e-05	0.000325	CcSEcCtD
Oxymorphone—Bradycardia—Doxorubicin—breast cancer	6.44e-05	0.000325	CcSEcCtD
Oxymorphone—Dyspnoea—Docetaxel—breast cancer	6.42e-05	0.000324	CcSEcCtD
Oxymorphone—Somnolence—Docetaxel—breast cancer	6.4e-05	0.000323	CcSEcCtD
Oxymorphone—Mental disorder—Methotrexate—breast cancer	6.4e-05	0.000323	CcSEcCtD
Oxymorphone—Dermatitis—Gemcitabine—breast cancer	6.39e-05	0.000322	CcSEcCtD
Oxymorphone—Eye disorder—Epirubicin—breast cancer	6.39e-05	0.000322	CcSEcCtD
Oxymorphone—Malnutrition—Methotrexate—breast cancer	6.36e-05	0.000321	CcSEcCtD
Oxymorphone—Headache—Gemcitabine—breast cancer	6.36e-05	0.000321	CcSEcCtD
Oxymorphone—Cardiac disorder—Epirubicin—breast cancer	6.35e-05	0.00032	CcSEcCtD
Oxymorphone—Flushing—Epirubicin—breast cancer	6.35e-05	0.00032	CcSEcCtD
Oxymorphone—Vomiting—Fluorouracil—breast cancer	6.35e-05	0.00032	CcSEcCtD
Oxymorphone—Dyspepsia—Docetaxel—breast cancer	6.34e-05	0.00032	CcSEcCtD
Oxymorphone—Insomnia—Capecitabine—breast cancer	6.31e-05	0.000318	CcSEcCtD
Oxymorphone—Dermatitis—Fluorouracil—breast cancer	6.29e-05	0.000317	CcSEcCtD
Oxymorphone—Decreased appetite—Docetaxel—breast cancer	6.26e-05	0.000316	CcSEcCtD
Oxymorphone—Hypersensitivity—Paclitaxel—breast cancer	6.26e-05	0.000316	CcSEcCtD
Oxymorphone—Headache—Fluorouracil—breast cancer	6.25e-05	0.000315	CcSEcCtD
Oxymorphone—Urinary tract disorder—Doxorubicin—breast cancer	6.25e-05	0.000315	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Docetaxel—breast cancer	6.22e-05	0.000314	CcSEcCtD
Oxymorphone—Dyspnoea—Capecitabine—breast cancer	6.22e-05	0.000313	CcSEcCtD
Oxymorphone—Fatigue—Docetaxel—breast cancer	6.21e-05	0.000313	CcSEcCtD
Oxymorphone—Angiopathy—Epirubicin—breast cancer	6.2e-05	0.000313	CcSEcCtD
Oxymorphone—Urethral disorder—Doxorubicin—breast cancer	6.2e-05	0.000313	CcSEcCtD
Oxymorphone—Nausea—Irinotecan—breast cancer	6.19e-05	0.000312	CcSEcCtD
Oxymorphone—Nausea—Mitoxantrone—breast cancer	6.19e-05	0.000312	CcSEcCtD
Oxymorphone—Immune system disorder—Epirubicin—breast cancer	6.18e-05	0.000311	CcSEcCtD
Oxymorphone—Mediastinal disorder—Epirubicin—breast cancer	6.16e-05	0.000311	CcSEcCtD
Oxymorphone—Constipation—Docetaxel—breast cancer	6.16e-05	0.000311	CcSEcCtD
Oxymorphone—Pain—Docetaxel—breast cancer	6.16e-05	0.000311	CcSEcCtD
Oxymorphone—Dyspepsia—Capecitabine—breast cancer	6.14e-05	0.00031	CcSEcCtD
Oxymorphone—Visual impairment—Doxorubicin—breast cancer	6.1e-05	0.000307	CcSEcCtD
Oxymorphone—Asthenia—Paclitaxel—breast cancer	6.1e-05	0.000307	CcSEcCtD
Oxymorphone—Decreased appetite—Capecitabine—breast cancer	6.06e-05	0.000306	CcSEcCtD
Oxymorphone—Nausea—Gemcitabine—breast cancer	6.03e-05	0.000304	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Capecitabine—breast cancer	6.02e-05	0.000304	CcSEcCtD
Oxymorphone—Fatigue—Capecitabine—breast cancer	6.01e-05	0.000303	CcSEcCtD
Oxymorphone—Pruritus—Paclitaxel—breast cancer	6.01e-05	0.000303	CcSEcCtD
Oxymorphone—Vision blurred—Methotrexate—breast cancer	6e-05	0.000302	CcSEcCtD
Oxymorphone—Mental disorder—Epirubicin—breast cancer	5.99e-05	0.000302	CcSEcCtD
Oxymorphone—Pain—Capecitabine—breast cancer	5.96e-05	0.000301	CcSEcCtD
Oxymorphone—Constipation—Capecitabine—breast cancer	5.96e-05	0.000301	CcSEcCtD
Oxymorphone—Malnutrition—Epirubicin—breast cancer	5.95e-05	0.0003	CcSEcCtD
Oxymorphone—Feeling abnormal—Docetaxel—breast cancer	5.94e-05	0.000299	CcSEcCtD
Oxymorphone—Nausea—Fluorouracil—breast cancer	5.93e-05	0.000299	CcSEcCtD
Oxymorphone—Eye disorder—Doxorubicin—breast cancer	5.91e-05	0.000298	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Docetaxel—breast cancer	5.89e-05	0.000297	CcSEcCtD
Oxymorphone—Flushing—Doxorubicin—breast cancer	5.87e-05	0.000296	CcSEcCtD
Oxymorphone—Cardiac disorder—Doxorubicin—breast cancer	5.87e-05	0.000296	CcSEcCtD
Oxymorphone—Flatulence—Epirubicin—breast cancer	5.87e-05	0.000296	CcSEcCtD
Oxymorphone—Tension—Epirubicin—breast cancer	5.84e-05	0.000295	CcSEcCtD
Oxymorphone—Diarrhoea—Paclitaxel—breast cancer	5.81e-05	0.000293	CcSEcCtD
Oxymorphone—Nervousness—Epirubicin—breast cancer	5.78e-05	0.000292	CcSEcCtD
Oxymorphone—Feeling abnormal—Capecitabine—breast cancer	5.75e-05	0.00029	CcSEcCtD
Oxymorphone—Angiopathy—Doxorubicin—breast cancer	5.74e-05	0.000289	CcSEcCtD
Oxymorphone—Immune system disorder—Doxorubicin—breast cancer	5.72e-05	0.000288	CcSEcCtD
Oxymorphone—Vertigo—Methotrexate—breast cancer	5.72e-05	0.000288	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Capecitabine—breast cancer	5.7e-05	0.000288	CcSEcCtD
Oxymorphone—Mediastinal disorder—Doxorubicin—breast cancer	5.7e-05	0.000288	CcSEcCtD
Oxymorphone—Abdominal pain—Docetaxel—breast cancer	5.69e-05	0.000287	CcSEcCtD
Oxymorphone—Body temperature increased—Docetaxel—breast cancer	5.69e-05	0.000287	CcSEcCtD
Oxymorphone—Dizziness—Paclitaxel—breast cancer	5.62e-05	0.000283	CcSEcCtD
Oxymorphone—Vision blurred—Epirubicin—breast cancer	5.61e-05	0.000283	CcSEcCtD
Oxymorphone—Mental disorder—Doxorubicin—breast cancer	5.54e-05	0.000279	CcSEcCtD
Oxymorphone—Urticaria—Capecitabine—breast cancer	5.54e-05	0.000279	CcSEcCtD
Oxymorphone—Body temperature increased—Capecitabine—breast cancer	5.51e-05	0.000278	CcSEcCtD
Oxymorphone—Abdominal pain—Capecitabine—breast cancer	5.51e-05	0.000278	CcSEcCtD
Oxymorphone—Convulsion—Methotrexate—breast cancer	5.51e-05	0.000278	CcSEcCtD
Oxymorphone—Malnutrition—Doxorubicin—breast cancer	5.51e-05	0.000278	CcSEcCtD
Oxymorphone—Agitation—Epirubicin—breast cancer	5.47e-05	0.000276	CcSEcCtD
Oxymorphone—Flatulence—Doxorubicin—breast cancer	5.43e-05	0.000274	CcSEcCtD
Oxymorphone—Chest pain—Methotrexate—breast cancer	5.42e-05	0.000273	CcSEcCtD
Oxymorphone—Tension—Doxorubicin—breast cancer	5.41e-05	0.000273	CcSEcCtD
Oxymorphone—Vomiting—Paclitaxel—breast cancer	5.4e-05	0.000272	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.38e-05	0.000271	CcSEcCtD
Oxymorphone—Dermatitis—Paclitaxel—breast cancer	5.35e-05	0.00027	CcSEcCtD
Oxymorphone—Nervousness—Doxorubicin—breast cancer	5.35e-05	0.00027	CcSEcCtD
Oxymorphone—Vertigo—Epirubicin—breast cancer	5.35e-05	0.00027	CcSEcCtD
Oxymorphone—Syncope—Epirubicin—breast cancer	5.34e-05	0.000269	CcSEcCtD
Oxymorphone—Headache—Paclitaxel—breast cancer	5.32e-05	0.000268	CcSEcCtD
Oxymorphone—Hypersensitivity—Docetaxel—breast cancer	5.31e-05	0.000268	CcSEcCtD
Oxymorphone—Palpitations—Epirubicin—breast cancer	5.26e-05	0.000265	CcSEcCtD
Oxymorphone—Confusional state—Methotrexate—breast cancer	5.23e-05	0.000264	CcSEcCtD
Oxymorphone—Loss of consciousness—Epirubicin—breast cancer	5.23e-05	0.000264	CcSEcCtD
Oxymorphone—Vision blurred—Doxorubicin—breast cancer	5.19e-05	0.000262	CcSEcCtD
Oxymorphone—Asthenia—Docetaxel—breast cancer	5.17e-05	0.000261	CcSEcCtD
Oxymorphone—Convulsion—Epirubicin—breast cancer	5.16e-05	0.00026	CcSEcCtD
Oxymorphone—Hypertension—Epirubicin—breast cancer	5.14e-05	0.000259	CcSEcCtD
Oxymorphone—Hypersensitivity—Capecitabine—breast cancer	5.14e-05	0.000259	CcSEcCtD
Oxymorphone—Pruritus—Docetaxel—breast cancer	5.1e-05	0.000257	CcSEcCtD
Oxymorphone—Nervous system disorder—Methotrexate—breast cancer	5.09e-05	0.000257	CcSEcCtD
Oxymorphone—Chest pain—Epirubicin—breast cancer	5.07e-05	0.000256	CcSEcCtD
Oxymorphone—Agitation—Doxorubicin—breast cancer	5.06e-05	0.000255	CcSEcCtD
Oxymorphone—Anxiety—Epirubicin—breast cancer	5.05e-05	0.000255	CcSEcCtD
Oxymorphone—Nausea—Paclitaxel—breast cancer	5.05e-05	0.000255	CcSEcCtD
Oxymorphone—Skin disorder—Methotrexate—breast cancer	5.04e-05	0.000254	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	5.03e-05	0.000254	CcSEcCtD
Oxymorphone—Hyperhidrosis—Methotrexate—breast cancer	5.02e-05	0.000253	CcSEcCtD
Oxymorphone—Asthenia—Capecitabine—breast cancer	5e-05	0.000252	CcSEcCtD
Oxymorphone—Dry mouth—Epirubicin—breast cancer	4.96e-05	0.00025	CcSEcCtD
Oxymorphone—Vertigo—Doxorubicin—breast cancer	4.95e-05	0.00025	CcSEcCtD
Oxymorphone—Anorexia—Methotrexate—breast cancer	4.95e-05	0.00025	CcSEcCtD
Oxymorphone—Syncope—Doxorubicin—breast cancer	4.94e-05	0.000249	CcSEcCtD
Oxymorphone—Pruritus—Capecitabine—breast cancer	4.93e-05	0.000249	CcSEcCtD
Oxymorphone—Diarrhoea—Docetaxel—breast cancer	4.93e-05	0.000248	CcSEcCtD
Oxymorphone—Confusional state—Epirubicin—breast cancer	4.9e-05	0.000247	CcSEcCtD
Oxymorphone—Palpitations—Doxorubicin—breast cancer	4.87e-05	0.000245	CcSEcCtD
Oxymorphone—Oedema—Epirubicin—breast cancer	4.86e-05	0.000245	CcSEcCtD
Oxymorphone—Hypotension—Methotrexate—breast cancer	4.85e-05	0.000245	CcSEcCtD
Oxymorphone—Loss of consciousness—Doxorubicin—breast cancer	4.84e-05	0.000244	CcSEcCtD
Oxymorphone—Shock—Epirubicin—breast cancer	4.78e-05	0.000241	CcSEcCtD
Oxymorphone—Convulsion—Doxorubicin—breast cancer	4.77e-05	0.000241	CcSEcCtD
Oxymorphone—Diarrhoea—Capecitabine—breast cancer	4.77e-05	0.000241	CcSEcCtD
Oxymorphone—Nervous system disorder—Epirubicin—breast cancer	4.76e-05	0.00024	CcSEcCtD
Oxymorphone—Dizziness—Docetaxel—breast cancer	4.76e-05	0.00024	CcSEcCtD
Oxymorphone—Hypertension—Doxorubicin—breast cancer	4.76e-05	0.00024	CcSEcCtD
Oxymorphone—Tachycardia—Epirubicin—breast cancer	4.74e-05	0.000239	CcSEcCtD
Oxymorphone—Skin disorder—Epirubicin—breast cancer	4.72e-05	0.000238	CcSEcCtD
Oxymorphone—Hyperhidrosis—Epirubicin—breast cancer	4.7e-05	0.000237	CcSEcCtD
Oxymorphone—Insomnia—Methotrexate—breast cancer	4.7e-05	0.000237	CcSEcCtD
Oxymorphone—Chest pain—Doxorubicin—breast cancer	4.69e-05	0.000236	CcSEcCtD
Oxymorphone—Anxiety—Doxorubicin—breast cancer	4.67e-05	0.000236	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.66e-05	0.000235	CcSEcCtD
Oxymorphone—Anorexia—Epirubicin—breast cancer	4.63e-05	0.000233	CcSEcCtD
Oxymorphone—Dyspnoea—Methotrexate—breast cancer	4.63e-05	0.000233	CcSEcCtD
Oxymorphone—Somnolence—Methotrexate—breast cancer	4.62e-05	0.000233	CcSEcCtD
Oxymorphone—Dizziness—Capecitabine—breast cancer	4.61e-05	0.000233	CcSEcCtD
Oxymorphone—Dry mouth—Doxorubicin—breast cancer	4.59e-05	0.000231	CcSEcCtD
Oxymorphone—Vomiting—Docetaxel—breast cancer	4.58e-05	0.000231	CcSEcCtD
Oxymorphone—Dyspepsia—Methotrexate—breast cancer	4.57e-05	0.00023	CcSEcCtD
Oxymorphone—Hypotension—Epirubicin—breast cancer	4.54e-05	0.000229	CcSEcCtD
Oxymorphone—Dermatitis—Docetaxel—breast cancer	4.54e-05	0.000229	CcSEcCtD
Oxymorphone—Confusional state—Doxorubicin—breast cancer	4.53e-05	0.000229	CcSEcCtD
Oxymorphone—Decreased appetite—Methotrexate—breast cancer	4.51e-05	0.000228	CcSEcCtD
Oxymorphone—Headache—Docetaxel—breast cancer	4.51e-05	0.000228	CcSEcCtD
Oxymorphone—Oedema—Doxorubicin—breast cancer	4.5e-05	0.000227	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Methotrexate—breast cancer	4.48e-05	0.000226	CcSEcCtD
Oxymorphone—Fatigue—Methotrexate—breast cancer	4.48e-05	0.000226	CcSEcCtD
Oxymorphone—Pain—Methotrexate—breast cancer	4.44e-05	0.000224	CcSEcCtD
Oxymorphone—Vomiting—Capecitabine—breast cancer	4.43e-05	0.000224	CcSEcCtD
Oxymorphone—Shock—Doxorubicin—breast cancer	4.42e-05	0.000223	CcSEcCtD
Oxymorphone—Nervous system disorder—Doxorubicin—breast cancer	4.41e-05	0.000222	CcSEcCtD
Oxymorphone—Insomnia—Epirubicin—breast cancer	4.39e-05	0.000222	CcSEcCtD
Oxymorphone—Dermatitis—Capecitabine—breast cancer	4.39e-05	0.000221	CcSEcCtD
Oxymorphone—Tachycardia—Doxorubicin—breast cancer	4.39e-05	0.000221	CcSEcCtD
Oxymorphone—Headache—Capecitabine—breast cancer	4.37e-05	0.00022	CcSEcCtD
Oxymorphone—Skin disorder—Doxorubicin—breast cancer	4.37e-05	0.00022	CcSEcCtD
Oxymorphone—Hyperhidrosis—Doxorubicin—breast cancer	4.35e-05	0.000219	CcSEcCtD
Oxymorphone—Dyspnoea—Epirubicin—breast cancer	4.33e-05	0.000218	CcSEcCtD
Oxymorphone—Somnolence—Epirubicin—breast cancer	4.32e-05	0.000218	CcSEcCtD
Oxymorphone—Anorexia—Doxorubicin—breast cancer	4.29e-05	0.000216	CcSEcCtD
Oxymorphone—Nausea—Docetaxel—breast cancer	4.28e-05	0.000216	CcSEcCtD
Oxymorphone—Feeling abnormal—Methotrexate—breast cancer	4.28e-05	0.000216	CcSEcCtD
Oxymorphone—Dyspepsia—Epirubicin—breast cancer	4.28e-05	0.000216	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Methotrexate—breast cancer	4.25e-05	0.000214	CcSEcCtD
Oxymorphone—Decreased appetite—Epirubicin—breast cancer	4.22e-05	0.000213	CcSEcCtD
Oxymorphone—Hypotension—Doxorubicin—breast cancer	4.2e-05	0.000212	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Epirubicin—breast cancer	4.19e-05	0.000211	CcSEcCtD
Oxymorphone—Fatigue—Epirubicin—breast cancer	4.19e-05	0.000211	CcSEcCtD
Oxymorphone—Pain—Epirubicin—breast cancer	4.15e-05	0.000209	CcSEcCtD
Oxymorphone—Constipation—Epirubicin—breast cancer	4.15e-05	0.000209	CcSEcCtD
Oxymorphone—Nausea—Capecitabine—breast cancer	4.14e-05	0.000209	CcSEcCtD
Oxymorphone—Urticaria—Methotrexate—breast cancer	4.12e-05	0.000208	CcSEcCtD
Oxymorphone—Abdominal pain—Methotrexate—breast cancer	4.1e-05	0.000207	CcSEcCtD
Oxymorphone—Body temperature increased—Methotrexate—breast cancer	4.1e-05	0.000207	CcSEcCtD
Oxymorphone—Insomnia—Doxorubicin—breast cancer	4.07e-05	0.000205	CcSEcCtD
Oxymorphone—Dyspnoea—Doxorubicin—breast cancer	4.01e-05	0.000202	CcSEcCtD
Oxymorphone—Feeling abnormal—Epirubicin—breast cancer	4e-05	0.000202	CcSEcCtD
Oxymorphone—Somnolence—Doxorubicin—breast cancer	4e-05	0.000201	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Epirubicin—breast cancer	3.97e-05	0.0002	CcSEcCtD
Oxymorphone—Dyspepsia—Doxorubicin—breast cancer	3.96e-05	0.0002	CcSEcCtD
Oxymorphone—Decreased appetite—Doxorubicin—breast cancer	3.91e-05	0.000197	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Doxorubicin—breast cancer	3.88e-05	0.000196	CcSEcCtD
Oxymorphone—Fatigue—Doxorubicin—breast cancer	3.88e-05	0.000195	CcSEcCtD
Oxymorphone—Urticaria—Epirubicin—breast cancer	3.86e-05	0.000195	CcSEcCtD
Oxymorphone—Pain—Doxorubicin—breast cancer	3.84e-05	0.000194	CcSEcCtD
Oxymorphone—Constipation—Doxorubicin—breast cancer	3.84e-05	0.000194	CcSEcCtD
Oxymorphone—Abdominal pain—Epirubicin—breast cancer	3.84e-05	0.000194	CcSEcCtD
Oxymorphone—Body temperature increased—Epirubicin—breast cancer	3.84e-05	0.000194	CcSEcCtD
Oxymorphone—Hypersensitivity—Methotrexate—breast cancer	3.83e-05	0.000193	CcSEcCtD
Oxymorphone—Asthenia—Methotrexate—breast cancer	3.72e-05	0.000188	CcSEcCtD
Oxymorphone—Feeling abnormal—Doxorubicin—breast cancer	3.7e-05	0.000187	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Doxorubicin—breast cancer	3.68e-05	0.000185	CcSEcCtD
Oxymorphone—Pruritus—Methotrexate—breast cancer	3.67e-05	0.000185	CcSEcCtD
Oxymorphone—Hypersensitivity—Epirubicin—breast cancer	3.58e-05	0.00018	CcSEcCtD
Oxymorphone—Urticaria—Doxorubicin—breast cancer	3.57e-05	0.00018	CcSEcCtD
Oxymorphone—Body temperature increased—Doxorubicin—breast cancer	3.55e-05	0.000179	CcSEcCtD
Oxymorphone—Abdominal pain—Doxorubicin—breast cancer	3.55e-05	0.000179	CcSEcCtD
Oxymorphone—Diarrhoea—Methotrexate—breast cancer	3.55e-05	0.000179	CcSEcCtD
Oxymorphone—Asthenia—Epirubicin—breast cancer	3.49e-05	0.000176	CcSEcCtD
Oxymorphone—Pruritus—Epirubicin—breast cancer	3.44e-05	0.000173	CcSEcCtD
Oxymorphone—Dizziness—Methotrexate—breast cancer	3.43e-05	0.000173	CcSEcCtD
Oxymorphone—Diarrhoea—Epirubicin—breast cancer	3.32e-05	0.000168	CcSEcCtD
Oxymorphone—Hypersensitivity—Doxorubicin—breast cancer	3.31e-05	0.000167	CcSEcCtD
Oxymorphone—Vomiting—Methotrexate—breast cancer	3.3e-05	0.000166	CcSEcCtD
Oxymorphone—Dermatitis—Methotrexate—breast cancer	3.27e-05	0.000165	CcSEcCtD
Oxymorphone—Headache—Methotrexate—breast cancer	3.25e-05	0.000164	CcSEcCtD
Oxymorphone—Asthenia—Doxorubicin—breast cancer	3.23e-05	0.000163	CcSEcCtD
Oxymorphone—Dizziness—Epirubicin—breast cancer	3.21e-05	0.000162	CcSEcCtD
Oxymorphone—Pruritus—Doxorubicin—breast cancer	3.18e-05	0.00016	CcSEcCtD
Oxymorphone—Vomiting—Epirubicin—breast cancer	3.09e-05	0.000156	CcSEcCtD
Oxymorphone—Nausea—Methotrexate—breast cancer	3.08e-05	0.000155	CcSEcCtD
Oxymorphone—Diarrhoea—Doxorubicin—breast cancer	3.08e-05	0.000155	CcSEcCtD
Oxymorphone—Dermatitis—Epirubicin—breast cancer	3.06e-05	0.000154	CcSEcCtD
Oxymorphone—Headache—Epirubicin—breast cancer	3.04e-05	0.000153	CcSEcCtD
Oxymorphone—Dizziness—Doxorubicin—breast cancer	2.97e-05	0.00015	CcSEcCtD
Oxymorphone—Nausea—Epirubicin—breast cancer	2.89e-05	0.000146	CcSEcCtD
Oxymorphone—Vomiting—Doxorubicin—breast cancer	2.86e-05	0.000144	CcSEcCtD
Oxymorphone—Dermatitis—Doxorubicin—breast cancer	2.83e-05	0.000143	CcSEcCtD
Oxymorphone—Headache—Doxorubicin—breast cancer	2.82e-05	0.000142	CcSEcCtD
Oxymorphone—Nausea—Doxorubicin—breast cancer	2.67e-05	0.000135	CcSEcCtD
Oxymorphone—OPRD1—Signaling Pathways—SERPINE1—breast cancer	7.97e-06	0.000133	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EGF—breast cancer	7.95e-06	0.000133	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—BRIP1—breast cancer	7.95e-06	0.000133	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—LDHB—breast cancer	7.95e-06	0.000133	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HPSE—breast cancer	7.95e-06	0.000133	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—KRAS—breast cancer	7.89e-06	0.000132	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HPGDS—breast cancer	7.83e-06	0.000131	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—FGFR1—breast cancer	7.83e-06	0.000131	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HBA1—breast cancer	7.78e-06	0.00013	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HIF1A—breast cancer	7.71e-06	0.000129	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—MAPK3—breast cancer	7.7e-06	0.000128	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NOS3—breast cancer	7.61e-06	0.000127	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTT1—breast cancer	7.6e-06	0.000127	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ACHE—breast cancer	7.6e-06	0.000127	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—BRAF—breast cancer	7.56e-06	0.000126	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ABCC1—breast cancer	7.53e-06	0.000126	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTA3—breast cancer	7.53e-06	0.000126	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HMMR—breast cancer	7.53e-06	0.000126	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—LEP—breast cancer	7.53e-06	0.000126	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CAV1—breast cancer	7.46e-06	0.000124	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KDR—breast cancer	7.38e-06	0.000123	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IGF1—breast cancer	7.36e-06	0.000123	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AKT2—breast cancer	7.36e-06	0.000123	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—EGFR—breast cancer	7.33e-06	0.000122	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PPARGC1B—breast cancer	7.3e-06	0.000122	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PIK3CA—breast cancer	7.25e-06	0.000121	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MDM2—breast cancer	7.22e-06	0.00012	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—RAF1—breast cancer	7.2e-06	0.00012	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP17A1—breast cancer	7.19e-06	0.00012	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ESR1—breast cancer	7.19e-06	0.00012	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—RELA—breast cancer	7.16e-06	0.00012	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ERBB2—breast cancer	7.12e-06	0.000119	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PTGS1—breast cancer	7.12e-06	0.000119	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ENO1—breast cancer	7.12e-06	0.000119	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—FN1—breast cancer	7.1e-06	0.000118	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CD—breast cancer	7.07e-06	0.000118	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MTOR—breast cancer	7.03e-06	0.000117	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CB—breast cancer	7.03e-06	0.000117	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NFKBIA—breast cancer	7.02e-06	0.000117	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PIK3CA—breast cancer	7e-06	0.000117	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SERPINE1—breast cancer	6.99e-06	0.000117	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOTCH1—breast cancer	6.95e-06	0.000116	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—KRAS—breast cancer	6.92e-06	0.000115	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTA4—breast cancer	6.89e-06	0.000115	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CA9—breast cancer	6.89e-06	0.000115	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NCOA2—breast cancer	6.85e-06	0.000114	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CG—breast cancer	6.8e-06	0.000113	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—APC—breast cancer	6.8e-06	0.000113	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KIT—breast cancer	6.8e-06	0.000113	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CXCL8—breast cancer	6.75e-06	0.000113	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EGF—breast cancer	6.72e-06	0.000112	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTA2—breast cancer	6.71e-06	0.000112	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GPX2—breast cancer	6.71e-06	0.000112	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—HRAS—breast cancer	6.71e-06	0.000112	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NOS3—breast cancer	6.67e-06	0.000111	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—FASN—breast cancer	6.64e-06	0.000111	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GPX4—breast cancer	6.63e-06	0.000111	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SULT1A1—breast cancer	6.63e-06	0.000111	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—BCHE—breast cancer	6.62e-06	0.00011	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CDKN1B—breast cancer	6.59e-06	0.00011	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—SLC5A5—breast cancer	6.54e-06	0.000109	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—AKT1—breast cancer	6.52e-06	0.000109	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—MAPK3—breast cancer	6.51e-06	0.000109	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTA1—breast cancer	6.48e-06	0.000108	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—IDH1—breast cancer	6.48e-06	0.000108	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CASP3—breast cancer	6.46e-06	0.000108	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL2—breast cancer	6.45e-06	0.000108	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL6—breast cancer	6.42e-06	0.000107	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NAT2—breast cancer	6.4e-06	0.000107	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—BRAF—breast cancer	6.39e-06	0.000107	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PIK3CA—breast cancer	6.36e-06	0.000106	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MDM2—breast cancer	6.33e-06	0.000106	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—SLC2A1—breast cancer	6.31e-06	0.000105	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NQO1—breast cancer	6.31e-06	0.000105	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—RAF1—breast cancer	6.31e-06	0.000105	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCND1—breast cancer	6.29e-06	0.000105	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—RELA—breast cancer	6.28e-06	0.000105	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—JUN—breast cancer	6.28e-06	0.000105	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ERBB2—breast cancer	6.24e-06	0.000104	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CTNNB1—breast cancer	6.23e-06	0.000104	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IGF1—breast cancer	6.22e-06	0.000104	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AKT2—breast cancer	6.22e-06	0.000104	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—EGFR—breast cancer	6.19e-06	0.000103	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MTOR—breast cancer	6.16e-06	0.000103	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CB—breast cancer	6.16e-06	0.000103	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP3A4—breast cancer	6.16e-06	0.000103	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MMP9—breast cancer	6.11e-06	0.000102	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CDKN1A—breast cancer	6.09e-06	0.000102	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PTEN—breast cancer	6.07e-06	0.000101	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP1B1—breast cancer	6.05e-06	0.000101	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CD—breast cancer	5.97e-06	9.97e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MAPK8—breast cancer	5.94e-06	9.91e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HSP90AA1—breast cancer	5.94e-06	9.9e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—AKT1—breast cancer	5.92e-06	9.88e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CXCL8—breast cancer	5.92e-06	9.88e-05	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PIK3CA—breast cancer	5.92e-06	9.87e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SERPINE1—breast cancer	5.91e-06	9.86e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—HRAS—breast cancer	5.88e-06	9.81e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—KRAS—breast cancer	5.85e-06	9.76e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CDKN1B—breast cancer	5.78e-06	9.65e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NCOA1—breast cancer	5.77e-06	9.63e-05	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—AKT1—breast cancer	5.72e-06	9.54e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—STK11—breast cancer	5.69e-06	9.49e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP19A1—breast cancer	5.69e-06	9.49e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CASP3—breast cancer	5.67e-06	9.45e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL2—breast cancer	5.66e-06	9.44e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOS3—breast cancer	5.64e-06	9.41e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SRC—breast cancer	5.63e-06	9.39e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL6—breast cancer	5.63e-06	9.39e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MED12—breast cancer	5.62e-06	9.37e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—DPYD—breast cancer	5.62e-06	9.37e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALDOA—breast cancer	5.53e-06	9.22e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCND1—breast cancer	5.52e-06	9.2e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—JUN—breast cancer	5.5e-06	9.18e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—VEGFA—breast cancer	5.48e-06	9.15e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CTNNB1—breast cancer	5.46e-06	9.11e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—STAT3—breast cancer	5.43e-06	9.06e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3CA—breast cancer	5.37e-06	8.96e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NCOA3—breast cancer	5.37e-06	8.95e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MMP9—breast cancer	5.35e-06	8.93e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MDM2—breast cancer	5.35e-06	8.93e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CDKN1A—breast cancer	5.34e-06	8.9e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—RAF1—breast cancer	5.33e-06	8.9e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SLC2A2—breast cancer	5.33e-06	8.89e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PTEN—breast cancer	5.32e-06	8.88e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—RELA—breast cancer	5.31e-06	8.86e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—COMT—breast cancer	5.29e-06	8.83e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ERBB2—breast cancer	5.28e-06	8.8e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTP1—breast cancer	5.26e-06	8.78e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ABCG2—breast cancer	5.22e-06	8.71e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MTR—breast cancer	5.22e-06	8.71e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CPT1A—breast cancer	5.22e-06	8.71e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAPK8—breast cancer	5.21e-06	8.69e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CB—breast cancer	5.21e-06	8.69e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MTOR—breast cancer	5.21e-06	8.69e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—AKT1—breast cancer	5.19e-06	8.67e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HMOX1—breast cancer	5.19e-06	8.66e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MAPK3—breast cancer	5.19e-06	8.65e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ITPR1—breast cancer	5.18e-06	8.64e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HPGDS—breast cancer	5.12e-06	8.54e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HBA1—breast cancer	5.09e-06	8.49e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MYC—breast cancer	5.05e-06	8.42e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TGFB1—breast cancer	5.03e-06	8.4e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CXCL8—breast cancer	5e-06	8.35e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ABCB1—breast cancer	4.98e-06	8.32e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—HRAS—breast cancer	4.97e-06	8.29e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ACHE—breast cancer	4.97e-06	8.29e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTT1—breast cancer	4.97e-06	8.29e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SRC—breast cancer	4.94e-06	8.24e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—EGFR—breast cancer	4.93e-06	8.23e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—TYMS—breast cancer	4.89e-06	8.17e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CDKN1B—breast cancer	4.89e-06	8.15e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTM1—breast cancer	4.84e-06	8.07e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PLA2G4A—breast cancer	4.84e-06	8.07e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NCOR1—breast cancer	4.84e-06	8.07e-05	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—AKT1—breast cancer	4.83e-06	8.06e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—VEGFA—breast cancer	4.81e-06	8.02e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CASP3—breast cancer	4.79e-06	7.99e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL2—breast cancer	4.78e-06	7.98e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—STAT3—breast cancer	4.76e-06	7.94e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL6—breast cancer	4.76e-06	7.94e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP17A1—breast cancer	4.7e-06	7.84e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—KRAS—breast cancer	4.66e-06	7.78e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCND1—breast cancer	4.66e-06	7.78e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ENO1—breast cancer	4.65e-06	7.76e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PTGS1—breast cancer	4.65e-06	7.76e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—JUN—breast cancer	4.65e-06	7.76e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GPX1—breast cancer	4.63e-06	7.73e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CTNNB1—breast cancer	4.62e-06	7.7e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP1A1—breast cancer	4.59e-06	7.65e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP2D6—breast cancer	4.56e-06	7.61e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ERCC2—breast cancer	4.55e-06	7.59e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAPK3—breast cancer	4.55e-06	7.59e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MMP9—breast cancer	4.53e-06	7.55e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CDKN1A—breast cancer	4.51e-06	7.52e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PTEN—breast cancer	4.5e-06	7.51e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NCOA2—breast cancer	4.48e-06	7.47e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MYC—breast cancer	4.42e-06	7.38e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TGFB1—breast cancer	4.41e-06	7.36e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAPK8—breast cancer	4.4e-06	7.34e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—AKT1—breast cancer	4.39e-06	7.32e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—FASN—breast cancer	4.34e-06	7.25e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EGFR—breast cancer	4.33e-06	7.22e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—BCHE—breast cancer	4.33e-06	7.22e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CA—breast cancer	4.28e-06	7.15e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—MTHFR—breast cancer	4.28e-06	7.13e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SLC5A5—breast cancer	4.27e-06	7.13e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SRC—breast cancer	4.17e-06	6.96e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TP53—breast cancer	4.14e-06	6.91e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SLC2A1—breast cancer	4.13e-06	6.89e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NQO1—breast cancer	4.13e-06	6.89e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KRAS—breast cancer	4.09e-06	6.82e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—VEGFA—breast cancer	4.06e-06	6.78e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—STAT3—breast cancer	4.02e-06	6.71e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HRAS—breast cancer	3.96e-06	6.61e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP1B1—breast cancer	3.96e-06	6.6e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CAV1—breast cancer	3.94e-06	6.58e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.88e-06	6.47e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAPK3—breast cancer	3.84e-06	6.41e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL6—breast cancer	3.79e-06	6.33e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NCOA1—breast cancer	3.77e-06	6.3e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CA—breast cancer	3.76e-06	6.27e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MYC—breast cancer	3.74e-06	6.24e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TGFB1—breast cancer	3.73e-06	6.22e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP19A1—breast cancer	3.72e-06	6.21e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—STK11—breast cancer	3.72e-06	6.21e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EGFR—breast cancer	3.66e-06	6.1e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TP53—breast cancer	3.63e-06	6.06e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CG—breast cancer	3.59e-06	5.99e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—AKT1—breast cancer	3.5e-06	5.84e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HRAS—breast cancer	3.47e-06	5.8e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—COMT—breast cancer	3.46e-06	5.77e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KRAS—breast cancer	3.45e-06	5.76e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTP1—breast cancer	3.44e-06	5.74e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HMOX1—breast cancer	3.39e-06	5.66e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ITPR1—breast cancer	3.39e-06	5.65e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL6—breast cancer	3.33e-06	5.55e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ABCB1—breast cancer	3.26e-06	5.44e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—TYMS—breast cancer	3.2e-06	5.34e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CA—breast cancer	3.17e-06	5.3e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NCOR1—breast cancer	3.16e-06	5.28e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.16e-06	5.28e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTM1—breast cancer	3.16e-06	5.28e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CD—breast cancer	3.16e-06	5.27e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALB—breast cancer	3.12e-06	5.2e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TP53—breast cancer	3.07e-06	5.12e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AKT1—breast cancer	3.07e-06	5.12e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GPX1—breast cancer	3.03e-06	5.05e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP1A1—breast cancer	3e-06	5e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NOS3—breast cancer	2.98e-06	4.98e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ERCC2—breast cancer	2.97e-06	4.96e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HRAS—breast cancer	2.94e-06	4.9e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL6—breast cancer	2.81e-06	4.69e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MTHFR—breast cancer	2.8e-06	4.66e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CB—breast cancer	2.75e-06	4.59e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PTGS2—breast cancer	2.73e-06	4.55e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AKT1—breast cancer	2.59e-06	4.33e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CAV1—breast cancer	2.58e-06	4.3e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PTEN—breast cancer	2.38e-06	3.97e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CG—breast cancer	2.35e-06	3.92e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CD—breast cancer	2.06e-06	3.45e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALB—breast cancer	2.04e-06	3.4e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NOS3—breast cancer	1.95e-06	3.25e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CB—breast cancer	1.8e-06	3e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PTGS2—breast cancer	1.78e-06	2.98e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CA—breast cancer	1.68e-06	2.8e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PTEN—breast cancer	1.56e-06	2.59e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—AKT1—breast cancer	1.37e-06	2.29e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CA—breast cancer	1.1e-06	1.83e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—AKT1—breast cancer	8.96e-07	1.5e-05	CbGpPWpGaD
